UltraSPECT marks 100th U.S. install

TriMed Staff | | Health Imaging | Practice Management
Nuclear medicine device developer UltraSPECT reported that the Haifa, Israel-based firm has achieved its 100th product installation in the U.S. The milestone was reached with the purchase of the company’s Xpress Cardiac application package by Atlanta Heart Specialists of Tucker, Ga.

Xpress Cardiac is connected to gamma cameras and enables half-time image acquisition, according to UltraSPECT. The application was connected to the four-cardiologist Atlanta Heart Specialists’ imaging network in late May this year and has been in daily clinical operation since that time, UltraSPECT said.

TriMed Staff

Related Content

MRI accident has prompted the company that installed the scanner to issue a safety warning
Newly launched report feature provides patients with a visual aid to their imaging
Center for Devices and Radiological Health hit with federal job cuts
Overview of the regulatory landscape of AI in radiology
Concerns about private equity's growing influence in radiology
'Ad hoc' shifts and radiology 'maestros': How one department addressed its workflow hiccups

Around the web

Cardiovascular Business
GE HealthCare launches new cardiac CT scanner with advanced AI capabilities

GE HealthCare designed the new-look Revolution Vibe CT scanner to help hospitals and health systems embrace CCTA and improve overall efficiency.

Cardiovascular Business
Bracco updates HeartSee coronary flow capacity software with new diagnostic features

Clinicians have been using HeartSee to diagnose and treat coronary artery disease since the technology first debuted back in 2018. These latest updates, set to roll out to existing users, are designed to improve diagnostic performance and user access.

Cardiovascular Business
Key trends in diagnostic heart testing: CT on the rise as some traditional techniques fall out of favor

The cardiac technologies clinicians use for CVD evaluations have changed significantly in recent years, according to a new analysis of CMS data. While some modalities are on the rise, others are being utilized much less than ever before.